Ceftazidime: Difference between revisions
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
'''Ceftazidime''' ([[International Nonproprietary Name|INN]]) ([[International Phonetic Alphabet|IPA]]: {{IPA|[kɛfˈtæzədim, sɛf-]}}) is a third-generation[[cephalosporin]] [[antibiotic]]. Like other third-generation cephalosporins, it has broad spectrum activity against [[Gram-positive]] and [[Gram-negative]][[bacteria]]. Unlike most third-generation agents, it is active against ''[[Pseudomonas aeruginosa]]'', however it has weaker activity against Gram-positive microorganisms and is not used for such infections. | '''Ceftazidime''' ([[International Nonproprietary Name|INN]]) ([[International Phonetic Alphabet|IPA]]: {{IPA|[kɛfˈtæzədim, sɛf-]}}) is a third-generation [[cephalosporin]] [[antibiotic]]. Like other third-generation cephalosporins, it has broad spectrum activity against [[Gram-positive]] and [[Gram-negative]][[bacteria]]. Unlike most third-generation agents, it is active against ''[[Pseudomonas aeruginosa]]'', however it has weaker activity against Gram-positive microorganisms and is not used for such infections. | ||
==Category== | ==Category== |
Revision as of 22:25, 26 December 2013
Ceftazidime |
---|
FORATZ®,TAZICEF®,CEFTAZIDIME® FDA Package Insert |
Description |
Clinical Pharmacology |
Microbiology |
Indications and Usage |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Overdosage |
Dosage and Administration |
Compatibility and stability |
Directions for use |
How Supplied |
Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ceftazidime (INN) (IPA: Template:IPA) is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negativebacteria. Unlike most third-generation agents, it is active against Pseudomonas aeruginosa, however it has weaker activity against Gram-positive microorganisms and is not used for such infections.
Category
Cephalosporin, Third-Generation
US Brand Names
FORTAZ®, TAZICEF®, CEFTAZIDIME®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings | Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages